Abcam plc (ABCM)의 가격은 얼마입니까?

Abcam plc (ABCM)의 가격은 $23.99입니다.

Abcam plc (ABCM)의 시가 총액은 무엇입니까?

Abcam plc (ABCM)의 시가 총액은 $4.90B입니다.

Abcam plc (ABCM) 수익

Abcam plc operates as a prominent life science enterprise, dedicated to the innovation, creation, and supply of crucial reagents and instruments. These fundamental resources are instrumental in supporting diverse scientific investigations, diagnostic applications, and the advancement of pharmaceutical drug discovery initiatives. Its comprehensive product portfolio features primary and secondary antibodies, conjugated antibodies paired with their respective kits, both singleplex and multiplex immunoassays, as well as a variety of proteins and peptides, including cytokines. Furthermore, the company provides edited cell lines, lysates, cellular activity kits, miRNA kits, biochemical compounds, and specialized tools for analyzing cell signaling pathways. Abcam serves a broad customer base, encompassing researchers and scientists within academic and institutional environments, alongside professionals at pharmaceutical, biotechnology, and diagnostic companies. The company boasts a global presence, conducting operations across the Americas, Europe, the Middle East, Africa, China, Japan, and the wider Asia Pacific region. Product distribution is primarily facilitated via its online platform. Founded in 1998, Abcam plc is headquartered in Cambridge, United Kingdom.

연도	수익	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

수익

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	수익	수익 차이	국가
Vertex Pharmaceuticals Incorporated VRTX.US	$5.27B	-	US
Argenx SE ARGX.US	$1.95B	-	NL
Moderna, Inc. MRNA.US	$-3.09B	-	US
CSL Limited CSL.AX	$-4.02B	-	AU
Lonza Group AG LONN.SW	-	-	CH

회사

수익

수익 차이

국가

Vertex Pharmaceuticals Incorporated

VRTX.US

$5.27B

Argenx SE

ARGX.US

$1.95B

Moderna, Inc.

MRNA.US

$-3.09B

CSL Limited

CSL.AX

$-4.02B

Lonza Group AG

LONN.SW

Abcam plc

ABCM

카테고리